352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
WisdomTree issued $345.0 million of 3.25% convertible senior notes due 2029 on August 13, 2024, which netted approximately $337 million in proceeds. On the same day, the company closed its repurchase of all 14,750 outstanding Series A Preferred shares from ETFS Capital Limited, which were convertible into 14,750,000 common shares. Shareholders could face dilution if the notes convert, as up to 35,751,281 common shares may be issued at the maximum conversion rate.
Notes: $345.0 million principal, 3.25% annual interest, maturing August 15, 2029; initial conversion price of approximately $11.82 per share
Net proceeds of approximately $337 million; the Initial Purchaser also exercised its option to buy $45.0 million of additional notes
Series A Preferred Stock: all 14,750 shares repurchased and retired, with the transaction closing August 13, 2024
Up to 35,751,281 common shares may be issued on conversion, based on the maximum conversion rate of 103.6269 shares per $1,000 principal
Elanco Animal Health entered an incremental assumption agreement under its existing senior secured credit facility, adding a new $350 million term loan. Proceeds will repay outstanding obligations under an existing term loan and fund general corporate purposes. The filing says the new facility's interest rate and repayment terms are generally consistent with the existing term loan.
New incremental term facility totals $350,000,000 under the Credit Agreement dated August 1, 2020
Proceeds will repay outstanding obligations under an existing term loan and for general corporate purposes
Facility matures on August 13, 2031; terms generally consistent with the existing term loan
Lenders include Farm Credit Mid-America, PCA as incremental term lender and Goldman Sachs Bank USA as term facility agent
KeyCorp entered an Investment Agreement with The Bank of Nova Scotia to sell common shares in two closings at a fixed price of $17.17 per share, for approximately $2.8 billion in aggregate consideration. After the second closing, the Bank of Nova Scotia would hold about 14.9% of KeyCorp's outstanding common shares and would be entitled to designate two board representatives.
Fixed price of $17.17 per share; aggregate consideration of approximately $2.8 billion
First closing gives the purchaser 4.90% of outstanding shares; second closing, subject to bank regulatory approvals, brings it to 14.90%
Two board designees upon the second closing; standstill limits the purchaser to 19.99% ownership
Purchaser's shares are locked up for one year after the second closing; shares issued under Section 4(a)(2) exemption
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.